Chan, Ying
Xu, Weiming
Feng, Yan
Zhang, Yan
Li, Suyun
Geng, Zibiao
Liu, Zhijiao
Zhao, Qingfen
Zhang, Jinman
Zhu, Baosheng
Funding for this research was provided by:
National Natural Science Foundation of China (82060039)
Major science and technology projects of Yunnan provincial S&T plan projects (2018ZF009)
Major Scientific and Technological Project of Yunnan Province, Yunnan Provincial Clinical Research Center for Birth Defects and Rare Diseases (2019ZF015)
Article History
Received: 22 December 2022
Accepted: 22 August 2023
First Online: 30 August 2023
Declarations
:
: Written informed consent was obtained before participation in the study. The study protocol is approved by the ethics committees of the First People’s Hospital of Yunnan Province. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors report no conflicts of financial interest.
: The authors’ team had been occupied the prevention and control of birth defects for more than twenty years and accumulated abundant clinical and basic research experience, especially on the fetal chromosomal abnormality clinical study. All authors are individually mentioned in the author contribution statement in the manuscript.